Introduction
If you’re researching tirzepatide vs semaglutide for weight loss or metabolic health, you’re not alone.
These medications have changed what’s possible in physician-supervised weight management, but they are not interchangeable.
At Protocol Health in Scarsdale, NY, GLP-1 therapy is paired with labs, lifestyle guidance, and ongoing medical support so treatment decisions are personalized to your goals, health history, and response.
See Which GLP-1 Is Right for YouQuick Answer
The biggest difference between tirzepatide and semaglutide
Semaglutide is a GLP-1 receptor agonist that helps regulate appetite, blood sugar, and digestion.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it targets two incretin pathways involved in appetite regulation and metabolic control.
Neither option is universally better. The right choice depends on your biology, health history, treatment goals, tolerability, and provider guidance.
Comparison
Tirzepatide vs Semaglutide: Side-by-Side Comparison
Both medications can support meaningful weight loss when used as part of a comprehensive plan. Tirzepatide often produces greater average weight loss, while semaglutide has strong evidence in certain cardiometabolic contexts.
Protocol Health evaluates labs, medical history, contraindications, and lifestyle context before recommending a medication pathway.
Effectiveness
Which GLP-1 helps you lose more weight?
In practical terms, both can work well, but tirzepatide often leads to more total weight loss on average.
That difference may matter for patients with a significant amount of weight to lose, but safety, adherence, side effects, access, and medical history are equally important.